These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Malignant carcinoid syndrome; case report with metabolic studies. KALANT N; BROTMAN HL; WISEMAN MH Can Med Assoc J; 1958 Sep; 79(5):389-92. PubMed ID: 13573286 [No Abstract] [Full Text] [Related]
4. [Clinical and biochemical studies in the carcinoid syndrome]. BLUMBERG A; DUBACH UC; KREIS W; MUELLER HR Dtsch Med Wochenschr; 1962 May; 87():921-9. PubMed ID: 13870227 [No Abstract] [Full Text] [Related]
5. Distribution of radioactive tryptophan in a patient with metastatic carcinoid. COLE JW; MATTHEWS LM AMA Arch Surg; 1958 Jun; 76(6):912-3. PubMed ID: 13532134 [No Abstract] [Full Text] [Related]
6. [Clinical physiopathology of carcinoid tumors]. ZAPATA APARICIO I Rev Esp Enferm Apar Dig Nutr; 1958; 17(7):751-72. PubMed ID: 13614859 [No Abstract] [Full Text] [Related]
7. [Biological study of a case of carcinoidosis; therapeutic perspectives]. BOULET P; BARJON P; CRASTES DE PAULET A Lyon Med; 1962 Feb; 94():289-99. PubMed ID: 13871820 [No Abstract] [Full Text] [Related]
9. [The carcinoid syndrome and serotonin]. HEDINGER C Helv Med Acta; 1958 Oct; 25(4):351-81. PubMed ID: 13610213 [No Abstract] [Full Text] [Related]
10. Clinical significance of derangements of tryptophan metabolism. A review of pellagra, carcinoid and H disease. FLEISCHMAJER R; HYMAN AB Arch Dermatol; 1961 Oct; 84():563-73. PubMed ID: 13893504 [No Abstract] [Full Text] [Related]
12. Carcinoid tumors and the carcinoid syndrome. Kazi MU; Grover V J Am Geriatr Soc; 1969 Aug; 17(8):807-16. PubMed ID: 5801424 [No Abstract] [Full Text] [Related]
13. Studies on tryptophan and serotonin in patients with malignant carcinoid. UDENFRIEND S; WEISSBACH H; SJOERDSMA A Science; 1956 Apr; 123(3199):669. PubMed ID: 13311520 [No Abstract] [Full Text] [Related]
14. The rapid degradation of 5-hydroxytryptamine (serotonin): significance in the carcinoid syndrome. JOHNSON LL; PESKIN GW; SENESKY DJ Surg Forum; 1961; 12():332-3. PubMed ID: 14452068 [No Abstract] [Full Text] [Related]
15. Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia. Swain CP; Tavill AS; Neale G Gastroenterology; 1976 Sep; 71(3):484-9. PubMed ID: 133045 [TBL] [Abstract][Full Text] [Related]
16. [Carcinoid syndrome (apropos of 1 case). II. Biologic study and therapeutic note]. Dreux C; Ingrand J Bull Mem Soc Med Hop Paris; 1967 Feb; 119(4):403-12. PubMed ID: 5596409 [No Abstract] [Full Text] [Related]
17. Carcinoid tumours--the carcinoid syndrome and serotonin (5-HT): a brief review. Donaldson D J R Soc Promot Health; 2000 Jun; 120(2):78. PubMed ID: 10944874 [No Abstract] [Full Text] [Related]
18. [The problem of metabolic processes in the yellow cell organ and carcinoid of the gastrointestinal tract]. FEYRTER F Wien Klin Wochenschr; 1959 Sep; 71():727-31. PubMed ID: 13822592 [No Abstract] [Full Text] [Related]
19. CLINICAL AND BIOCHEMICAL EFFECTS OF CYCLOPHOSPHAMIDE IN PATIENTS WITH MALIGNANT CARCINOID. MENGEL CE; KELLY MG; CARBONE PP; ANLYAN WG Am J Med; 1965 Mar; 38():396-404. PubMed ID: 14266830 [No Abstract] [Full Text] [Related]
20. Serotonin release from carcinoid tumours. JONES WP Can Anaesth Soc J; 1962 Jan; 9():42-50. PubMed ID: 14452357 [No Abstract] [Full Text] [Related] [Next] [New Search]